Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Idiopathic Restless Legs Syndrome (RLS)”

7 trials

Showing 7 of 7 results

Post-approval studies (Phase 4)Study completedNCT00472199
What this trial is testing

Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS)

Who this might be right for
Restless Legs Syndrome
Boehringer Ingelheim 331
Large-scale testing (Phase 3)Study completedNCT01569464
What this trial is testing

Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS)

Who this might be right for
Restless Legs Syndrome
UCB Pharma 150
Large-scale testing (Phase 3)Study completedNCT00357097
What this trial is testing

The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome

Who this might be right for
Restless Legs SyndromeModerate to Severe Idiopathic Restless Legs Syndrome (RLS)
GlaxoSmithKline 240
Not applicableStudy completedNCT01386944
What this trial is testing

Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced Augmentation

Who this might be right for
Restless Legs Syndrome
UCB Pharma 102
Large-scale testing (Phase 3)Study completedNCT01112644
What this trial is testing

Oxycodone/Naloxone Prolonged Release (OXN PR) Compared to Placebo to Demonstrate Improvement in Symptoms of Restless Legs Syndrome (RLS) in Subjects With Moderate to Severe Idiopathic RLS With Daytime Symptoms

Who this might be right for
Moderate to Severe Idiopathic RLS With Daytime Symptoms
Mundipharma Research GmbH & Co KG 205
Large-scale testing (Phase 3)Study completedNCT00275457
What this trial is testing

Efficacy and Safety of Pramipexole (PPX) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) Patients

Who this might be right for
Restless Legs Syndrome
Boehringer Ingelheim 346
Testing effectiveness (Phase 2)Study completedNCT01521663
What this trial is testing

Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)

Who this might be right for
Restless Legs Syndrome
Impax Laboratories, LLC 159

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation